Director/PDMR Shareholding

1 August 2013

Director /PDMR Shareholding

Synergy Health plc

("Synergy", the "Company", or the "Group")

1 August 2013

The Company announces the following transactions by certain directors and persons discharging managerial responsibilities ("PDMR"), in Synergy Health plc ordinary shares of 0.625 pence each ("Ordinary Shares") and the consequent allocations of Ordinary Shares to the LTIP Co-Invest Scheme.

1) Mr Tim Mason, Group Company Secretary, has today exercised options over 8,744 ordinary shares under the Company's Executive Share Option Scheme and has also exercised options over 16,283 Ordinary Shares under the Company's LTIP Scheme. Of these shares 21,564 have been sold at a price of 1105p per share. The balance of 3,463 shares have been retained by Mr Mason and allocated to the LTIP Co-Invest Scheme. Following this transaction Mr Mason has an interest in 10,063 Ordinary Shares representing 0.02% of the Company's issued share capital.

2) Dr Adrian Coward, CEO UK and Ireland, has today exercised options over 28,821 Ordinary Shares under the Company's LTIP Scheme and subsequently sold 21,518 Ordinary Shares at a price of 1105p per share. The remaining 7,303 shares have been retained by Dr Coward and allocated to the LTIP Co-Invest Scheme. Following the transaction Dr Coward has an interest in 31,298 shares representing 0.05% of the Company's issued share capital.

3) Mr Paul Santing, Group Commercial Director, has today exercised options over 30,988 Ordinary Shares under the Company's LTIP scheme and subsequently sold 19,750 Ordinary Shares at a price of 1105p per share. Of the remaining 11,238 Ordinary Shares retained, 3,441 Ordinary Shares have been allocated to the Company's Co-Invest Scheme. Following the transaction Mr Santing has an interest in 40,288 Ordinary Shares representing 0.07% of the Company's issued share capital.

As a result of the above allocations to the Company's Co-Invest Scheme, the following grants have been duly made:-

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.

For further information:

Synergy Health plc

Tim Mason

Group Company Secretary Tel+44 (0) 1793 891 862